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Summary
 
The c-
 
rel
 
 protooncogene encodes a member of the Rel/nuclear factor (NF)-
 
k
 
B family of tran-
scriptional factors. To assess the role of the transcriptional activation domain of c-Rel in vivo,
we generated mice expressing a truncated c-Rel (
 
D
 
c-Rel) that lacks the COOH-terminal re-
gion, but retains a functional Rel homology domain. Mice with an homozygous mutation in
 
the c-
 
rel
 
 region encoding the COOH terminus of c-Rel (c-
 
rel
 
D
 
CT/
 
D
 
CT
 
) display marked defects
in proliferative and immune functions. c-
 
rel
 
D
 
CT/
 
D
 
CT
 
 animals present histopathological alterations
of hemopoietic tissues, such as an enlarged spleen due to lymphoid hyperplasia, extramedullary
 
hematopoiesis, and bone marrow hypoplasia. In older c-
 
rel
 
D
 
CT/
 
D
 
CT
 
 
 
mice, lymphoid hyperplasia
was also detected in lymph nodes, liver, lung, and stomach. These animals present a more se-
vere phenotype than mice lacking the entire c-Rel protein. Thus, in c-
 
rel
 
D
 
CT/
 
D
 
CT
 
 
 
mice,
 
 
 
the lack
of c-Rel activity is less efficiently compensated by other NF-
 
k
 
B proteins.
 
T
 
he c-
 
rel 
 
protooncogene encodes a transcription factor
that belongs to the family of Rel/nuclear factor (NF)
 
1
 
-
 
k
 
B
proteins that play an important role in the expression of
genes involved in immune and inflammatory responses (1–10).
Rel/NF-
 
k
 
B proteins represent a group of homo- and het-
erodimeric complexes that are related through a common
NH
 
2
 
-terminal domain known as the Rel homology do-
 
main (RHD), which consists of 
 
z
 
300 amino acids and con-
tains sequences important for protein dimerization, DNA
binding, nuclear localization, and association with inhibitors
of the I
 
k
 
B family. The COOH termini of Rel proteins
have little sequence similarity and have been used to distin-
guish two classes of Rel proteins. One class includes NF-
 
k
 
B1
(protein [p]105/p50) and NF-
 
k
 
B2 (p100/p52), which, by
proteolytic processing, generates the mature DNA-binding
subunits p50 and p52, respectively. The second class in-
cludes c-Rel, RelA (p65), and RelB, which contain tran-
scriptional activation domains in their COOH termini.
The genes of the Rel/NF-
 
k
 
B family are differentially ex-
pressed in lymphoid tissues (11–12) and studies with mice
lacking either p50, RelB, RelA, or c-Rel demonstrate that
individual members of this family have distinct functions in
vivo (for review see reference 13).
Activation NF-
 
k
 
B is regulated by posttranslational mod-
ification and degradation of I
 
k
 
B proteins that interact with
the Rel/NF-
 
k
 
B complexes and sequester them in the cyto-
plasm by masking their nuclear localization signal. Mem-
bers of the I
 
k
 
B family include I
 
k
 
B
 
a
 
, I
 
k
 
B
 
b
 
, I
 
k
 
B
 
g
 
, I
 
k
 
B
 
e
 
,
Bcl-3, p105, and p100, which share conserved ankyrin-like
repeats responsible for interaction with the Rel/NF-
 
k
 
B
complexes. In the case of I
 
k
 
B
 
a
 
, phosphorylation and sub-
sequent degradation of the inhibitor releases the active
Rel/NF-
 
k
 
B complexes allowing their nuclear transloca-
 
tion. Degradation of I
 
k
 
B
 
a
 
 
 
is mediated by the ubiquitin–
proteasome pathway, and phosphorylation of I
 
k
 
B
 
a
 
 in-
volves a ubiquitin-dependent protein kinase (4, 7, 8, 10,
14–16). 
The mammalian c-
 
rel
 
 gene was first identified as the cel-
lular homologue of v-
 
rel
 
, the oncogene carried by Rev-T,
an acutely transforming avian retrovirus that induces a vari-
ety of neoplastic diseases in chickens. Rearrangements in
the c-
 
rel 
 
gene have been associated with human lymphoid
 
1
 
Abbreviations used in this paper:
 
 
 
D
 
c-Rel, truncated c-Rel; CAT, chloram-
phenicol acetyl transferase; CD, cluster of differentiation; EMSA, electro-
phoretic mobility shift assay; ES, embryonic stem; GC, germinal center;
Gr-1, granulocyte 1; LCMV, lymphocytic choriomeningitis virus; Mac-1,
macrophage 1; mCD40L, ligand for the mouse CD40; NF, nuclear fac-
tor; p, protein; p(A), polyadenylation sequence; PGK, phosphoglycerate
kinase; pPNT, plasmid PGK promoter neomycin thymidine kinase;
RHD, Rel homology domain; Ter, total erythroid cells.
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malignancies. Similar to v-
 
rel
 
, the altered c-
 
rel
 
 genes lack
sequences encoding the transcriptional activation domain
(17–20). The in vivo roles of the c-
 
rel
 
 gene have been re-
cently addressed by gene targeting. Mice lacking the c-Rel
protein (
 
c-rel
 
2/2
 
) exhibit defects in lymphocyte prolifera-
tion, humoral immunity, and cytokine production (21–23).
To understand the in vivo
 
 
 
role of c-Rel in greater detail,
we have generated mice lacking only the COOH-terminal
transcriptional activation domain of c-Rel (c-
 
rel
 
D
 
CT/
 
D
 
CT
 
).
This transcriptionally inactive molecule retains an intact
RHD, is able to bind DNA, and to interact with other
Rel/NF-
 
k
 
B family members and the I
 
k
 
B
 
 
 
family of inhibi-
tory molecules. Therefore, in c-
 
rel
 
D
 
CT/
 
D
 
CT 
 
mice, other Rel/
NF-
 
k
 
B family members do not have the possibility of tak-
ing the function of c-Rel, as in the case of 
 
c-rel
 
2/2
 
 mice. In
addition, this approach allows us to address the functional
significance of the different transcriptional activation do-
mains present in c-Rel, RelA, and RelB, and the role of
c-Rel COOH-terminal truncations in the generation of
lymphoid malignancies.
 
Materials and Methods
 
Targeting Vector and Generation of Mutant Mice. 
 
A genomic li-
brary (cloned in lambda DashII; Stratagene Corp., La Jolla, CA)
prepared from D3 embryonic stem (ES) cell DNA was screened
with the mouse 
 
c-rel 
 
cDNA probe (24). Two overlapping phages
containing a total of 25 kbp of the c-
 
rel
 
 gene were isolated and
the fragments were subcloned into pBluescript KS
 
1
 
 (Stratagene
Corp.). A 0.9-kbp fragment containing the SV40 polyadenylation
sequence [p(A)] and a termination codon was prepared by PCR
mutagenesis using the pMSG vector (Pharmacia, Piscataway, NJ)
and subcloned in the plasmid PGK promoter neomycin thymi-
dine kinase (pPNT) vector (25). A 4.7-kbp c-
 
rel
 
 genomic DNA
fragment containing exons 7–9 and the first portion of exon 10
(until the XhoI
 
 
 
site) was inserted upstream of the stop codon and
between the phosphoglycerate kinase (PGK)-
 
neo
 
 cassette and the
PGK promoter driving the herpes simplex virus thymidine kinase
gene (PGK–
 
tk
 
 cassette) of a pPNT vector containing the termina-
tion codon. A 8.5-kbp fragment from c-
 
rel
 
 genomic DNA ex-
tending from the XhoI site of exon 10 to the flanking 3
 
9
 
 genomic
sequences was cloned upstream and in opposite direction to the
PGK–
 
neo
 
 cassette of the pPNT vector. In this way, the genomic
c-
 
rel 
 
gene was interrupted by the neo selection marker in exon 10.
Introduction of the stop codon 3
 
9
 
 to the XhoI restriction site
produces a truncated c-
 
rel
 
 messenger RNA that lacks the region
encoding the truncated c-Rel (
 
D
 
c-Rel) transactivation domain
(pPNT/
 
D
 
c-Rel). 
CJ7 ES cells were electroporated with NotI-linearized pPNT/
 
D
 
c-Rel and grown under double selection conditions using G418
and fialuridine (FIAU). Homologous recombination events were
screened by Southern blot analysis using a 5
 
9
 
 external probe, and
additional random integrations were excluded with a 
 
neo
 
 probe
(Fig. 1 
 
A,
 
 and data not shown). Homozygous mutant animals
were prepared as described (26).
 
Histology, Immunofluorescence, Immunohistochemistry, and Flow Cy-
tometry. 
 
Tissues were immersion fixed in 10% buffered formalin
and embedded in paraffin blocks. Sections were stained with hema-
toxylin and eosin. Apoptotic cells were detected with the Apoptag
assay and stained with methyl green according to Oncor, Inc.
(Gaithersburg, MD). For detection of germinal centers (GCs),
mice were immunized with SRBCs, and frozen sections of spleen
were prepared and stained as described (27). Flow cytometry
analysis was performed as described (26, 28). Anti–mouse mac-
rophage 1 (Mac-1), granulocyte 1 (Gr-1), and total erythroid cells
(Ter) 119 were obtained from GIBCO BRL (Gaithersburg, MD).
 
In Vitro Proliferation, Listeria Monocytogenes, and Lymphocytic Chorio-
meningitis Virus Infections. 
 
B cell proliferation assays were per-
formed as described (29). Lymph node T cells were purified by
murine T cell enrichment columns (R&D Systems, Inc., Minne-
apolis, MN) and (105) cells in 96-well plates were stimulated with
IL-2 or with cluster of diffentiation (CD)3 plus CD28 coated an-
tibodies (PharMingen, San Diego, CA) in 200 ml medium for 48 h.
Cell proliferation was measured after 12 h of culture by [3H]thy-
midine incorporation in a scintillation spectroscopy. Results are
expressed as the arithmetic mean 6 SD of triplicate cultures. 
Adult mice were injected intraperitoneally with 2,500 CFU of
L. monocytogenes and killed after 5 d. Animals were killed after 5 d
or on day 4 of infection when moribund. Numbers of viable L.
monocytogenes in lung, liver, and spleen of infected animals were
determined by plating serial dilutions of organ homogenates in
PBS on sheep blood agar. Other mice were injected intraperito-
neally with 1.2 3 105 PFU (Armstrong strain) of Lymphocytic
Choriomeningitis Virus (LCMV) and killed 3 or 7 d later. Infec-
tious LCMV titers of lung, liver, and spleen (PFU/g tissue) were
quantitated by plaque assay using Vero cell monolayers as de-
scribed (30). Data from six to nine animals per genotype were re-
corded for each experiment.
Thioglycollate-induced Peritonitis, Granuloma Formation, and Nitric
Oxide Production.  Peritoneal macrophages were prepared 5 d
after intraperitoneal injection with 1.5 ml sterile Brewers thiogly-
collate broth (3%) as described (31). Three cell preparations from
the various genotypes were used in in vitro experiments. Lung
granuloma formation was induced by glucan tail injection (32).
For nitric oxide synthase (NOS) assays, resting peritoneal mac-
rophages (5 3 105/0.5 ml DMEM in a 24-well plate) were
treated for 72 h with LPS (1 mg/ml) alone or in combination
with IFN-g (100 U/ml). NO was measured as nitrite with Greiss
reagent (33).
ELISA.  Purified lymph node T cells (5 3 105/ml) isolated
from 6-wk-old mice were incubated with or without coated anti-
CD3 and anti-CD28 antibodies for 72 h. Macrophages were
stimulated for 2 h with media alone or in the presence of a com-
bination of LPS (1 mg/ml) and IFN-g (100 U/ml). Cytokine lev-
els in supernatants were determined by ELISA (R&D Systems,
Inc.). All cultures were done in triplicate.
Immunoprecipitation and Electrophoretic Mobility Shift Assays.  Sple-
nocytes from 6-wk-old animals were isolated as described (28)
and labeled with 800 mCi/ml of [35S]methionine (Amersham
Corp., Arlington Heights, IL) for 6 h. Cells were lysed directly in
13 RIPA buffer, followed by immunoprecipitation as described
(34). For electrophoretic mobility shift assays (EMSAs), nuclear
extracts were prepared and incubated with a palindromic kB site
as described (35). Protein loading was normalized by comparing
Oct 1 DNA-binding activity. 
Expression Vectors, Cell Culture, and Transfections. Expression vec-
tors for p50, RelA, c-Rel, and Dc-Rel were constructed by cloning
the corresponding coding regions into the mammalian expression
vector pMexneo as described (36). S107 cells were cotransfected
using the standard calcium phosphate coprecipitation method (37).
Typically, 2 mg of reporter vector and 0.5 mg of each of the expres-
sion vectors were used. The reporter vector, 23 kB-tk-CAT (38;
CAT, chloramphenicol acetyl transferase), containing two kB-
binding sites from the mouse immunoglobulin kB enhancer, was975 Carrasco et al.
used in all experiments. The standard reaction for CAT enzyme as-
say was performed according to manufacturer’s recommendations
(Promega Corp., Madison, WI). Reactions were normalized for lu-
ciferase levels and protein concentration.
Results
Generation of Mice Lacking the Transcriptional Activation Do-
main of c-Rel.  A targeted disruption of the transcriptional
activation domain of c-rel was created by introducing a ter-
mination signal at codon 366 followed by SV40 p(A) and a
PGK–neo cassette (Fig. 1 A). After electroporation and se-
lection, 200 double-resistant CJ7 ES cell clones were picked
and screened by Southern blot analysis (Fig. 1 B). Homolo-
gous recombination in 11 clones was identified by the ap-
pearance of a 18.5-kbp recombinant band in addition to the
25-kbp wild-type band in XbaI-digested DNA (Fig. 1 B a).
Eight chimeric males transmitted the ES cell–derived agouti
coat and the targeted c-rel gene to their offspring (data not
shown). Intercrosses between heterozygous animals pro-
duced progeny with normal Mendelian transmission of the
disrupted c-rel allele according to genotypic PCR analysis
(Fig. 1 B b).
Expression of c-Rel Lacking the Transcriptional Activation Do-
main in Splenocytes.  Whole cell lysates from mouse spleno-
cytes labeled with [35S]methionine were immunoprecipitated
with a c-Rel antiserum raised against the RHD. The results
demonstrated that homozygous mutant mice (c-relDCT/DCT)
lacked c-Rel, but expressed the truncated c-Rel protein,
Dc-Rel (Fig. 1 B c). In heterozygous mice (c-rel1/DCT), both
the normal c-Rel and the truncated Dc-Rel proteins are
detected. We further studied selected protein interactions
of Dc-Rel (Fig. 1 C). After immunoprecipitation with c-Rel
antibodies under nondenaturing conditions, the immunocom-
Figure 1. Generation of mice
lacking the transcriptional activa-
tion domain of c-Rel. (A) The
targeting vector for positive–
negative selection, pPNT/Dc-
Rel is shown at the top. Open
boxes, the SV40 p(A), the PGK–
neo, and the PGK–tk cassettes.
Homologous recombination of
the targeting vector with wild-
type genomic DNA introduces
the neo selection marker at the
beginning of exon 10 (bottom).
The targeted allele and the
length of diagnostic restriction
fragments used for Southern blot analyses and the probe fragment are indicated. (B) Screening of ES cells and mice generated from heterozygote inter-
crosses and expression of Dc-Rel protein. (B a) ES cell genomic DNAs were digested with XbaI and subjected to Southern blot analysis using the 59 ex-
ternal probe. The 25-kbp band (wt) indicates the wild-type allele, whereas the 18.5-kbp band (ko) represents the targeted allele. (B b) Tail DNAs were
prepared and subjected to PCR analyses using an appropriate pair of c-rel and neo oligonucleotides. Wild-type mice presented a single band, c-rel; het-
erozygous mice showed two bands, c-rel and neo; and the homozygous mice showed a single band, neo. (B c) Total protein extract from wild-type (1/1),
heterozygous (1/DCT), and homozygous (DCT/DCT) mutant splenocytes labeled with [35S]methionine were immunoprecipitated with an anti–c-Rel/
RHD antiserum. Specific signals for c-Rel and Dc-Rel are indicated. (C) Dc-Rel interacts with other Rel/NF-kB proteins. Total protein extract from wild-
type (left) and homozygous (right) mutant splenocytes labeled with [35S]methionine were first immunoprecipitated with an anti–c-Rel/RHD antiserum,
and the complexes were denatured and reprecipitated with the indicated specific antisera. 976 Mice Lacking the Transcriptional Activation Domain of c-Rel
plexes were dissociated and then sequentially reprecipitated
with p50, RelA, and IkBa antibodies. The immunoprecip-
itation patterns observed in control (Fig. 1 C, left) and in
Dc-Rel (Fig. 1 C, right) cells were similar, indicating that
Dc-Rel, by virtue of its intact RHD, maintains normal inter-
actions with other Rel/NF-kB family members and IkBa.
Histopathological Alterations in c-relDCT/DCT Mutant Mice.
Young c-relDCT/DCTmice, between 3 and 8 wk old, appeared
normal as assessed by habit, weight, posture, and histologic
and flow cytometric analysis of lymphoid cells (data not
shown). However, after 5 to 7 mo of age, an increasing
number of animals began to develop exzematoid skin le-
sions around the nose, eyes, ears, tail, and foreskin. These
lesions were not related to infection, according to microbi-
ologic testing and serologic analysis (not shown). The dis-
ease progressed slowly, without severely compromising the
health status and survival of c-relDCT/DCT mice if the animals
were kept in microisolators. However, when c-relDCT/DCT
mice were left in a non–pathogen-free environment, their
survival was reduced compared with control littermates
(data not shown). Apparently, healthy and sick c-relDCT/DCT
mice were systematically analyzed by histopathology. A con-
stant observation was the presence of enlarged spleens, lymph
nodes, and in 30% of the cases analyzed, the presence of pale
bones and changes in the color and consistency of the stom-
ach, liver, and lung (Fig. 2, a and b, and data not shown).
The TUNEL assay revealed increased numbers of apop-
totic nuclei inside of macrophages in medullary areas of the
thymus and within the marginal zone of the spleen in c-
relDCT/DCT mice (Fig. 2, c and d, and data not shown). This
result is in agreement with recent reports documenting a
role of Rel/NF-kB in preventing apoptosis (39–41). 
Staining of mutant spleen sections revealed increased
white and red pulp areas when compared with control tissue
(Fig. 2, e and f ). Analysis at higher magnification revealed
mild to moderate increase of normoblast and megakaryo-
cytes and a reduced number of metachromatic macrophages
in red pulp areas of spleens from c-relDCT/DCT mice (data not
shown). Reduced cellularity and increased empty spaces were
observed in the bone marrow of c-relDCT/DCT mice that pre-
sented macroscopic alterations in the bones (Fig. 2, g and h).
Lymphoid cellular infiltration was observed in tissues of the
mutant mice with enlarged lymph nodes and macroscopic
alterations in the stomach, liver, and lung (Fig. 2, i–l). 
The previous observations suggests an essential role of
c-Rel in normal bone marrow hematopoiesis and lym-
phoid development. Since these changes were not ob-
served in wild-type and heterozygous c-rel1/DCTmice, Dc-
Rel does not behave as a trans-dominant mutant of c-Rel. 
Bone Marrow Hypoplasia, Extramedullary Hematopoiesis, and
Lymphoid Hyperplasia in c-relDCT/DCT Mice. Flow cytometric
analysis of hemopoietic cells from young c-relDCT/DCT mice
Figure 2. Histopathology of
c-relDCT/DCT mice. Necropsies of
5–7-mo-old c-relDCT/DCT mice
reveals splenomegaly (a) and bone
marrow hypoplasia (b). Thymus
tissue sections from 4-wk-old
control (c) and c-relDCT/DCT (d)
mice were stained with the
TUNEL procedure. (d, inset)
Apoptotic nucleus. Spleen (e and
f) and bone marrow (g and h)
sections from 5-mo-old control
(e and g) and c-relDCT/DCT (f and
h) mice were stained with hema-
toxylin and eosin. (g, inset) Mac-
rophages containing iron parti-
cles. Photomicrographs were
taken at magnifications of 100 (c,
d, g, and h), 12.5 (e and f), and
250 (d and g, insets). WT, wild
type; WP, white pulp; RP, red
pulp. Tissue sections from lymph
nodes (i), stomach (j), liver (k),
and lung (l) from 5-mo-old
c-relDCT/DCT mice revealed lym-
phoid hyperplasia (arrows). Photo-
micrographs were taken at mag-
nifications of 6.25 (i) and 25 (j, k,
and l). 977 Carrasco et al.
did not show major alterations in the expression of the sur-
face markers in cells derived from thymus (CD4, CD8, and
TCR-a/b), spleen (CD4, CD8, TCR-a/b, CD25, Mac-1,
Gr-1, B220, IgM, IgK, and Ter 119), and bone marrow
(Ter 119, IgM, IgK, and B220) (data not shown). How-
ever, after 5 mo of age, alterations began to be detected in
c-relDCT/DCT mice (Fig. 3, A and B). For instance, in agree-
ment with the hypocellularity observed in bone marrow at
histopathology, a reduced percentage of macrophages (Fig.
3 A, a and b) and erythroid precursors (Fig. 3 A, c and d)
was detected in bone marrow–derived cells from c-relDCT/DCT
mice, but not in control littermates. In addition, a concom-
itant and graded increase in the number of erythroid pre-
cursors (Fig. 3 B, a and b) and granulocytes (Fig. 3 B, c and
d) was observed in the enlarged spleens from c-relDCT/DCT
mice, reflecting the presence of extramedullary hemato-
poiesis. When B cell markers were used in flow cytometric
analysis, a 1.5–2.5-fold increase in the total number and
percentage of B cells was observed in the enlarged spleens
of c-relDCT/DCT mice, correlating with the enlarged white
pulp areas (Fig. 3 C, and data not shown). Immunostaining of
control (Fig. 3 C a) and c-relDCT/DCT (Fig. 3 C b) splenic tis-
sue sections with anti–Mac-1 revealed a dramatic enlarge-
ment of the lymphatic follicles with compression and dis-
placement of the red pulp to the periphery of the organ. A
concomitant reduction of Mac-1 positive cells in the red
pulp between the follicles was also observed. Labeling with
anti-B220 antibodies revealed diffusely enlarged white pulp
areas with poorly demarcated white/red pulp boundaries,
marginal zones, and periarterial lymphatic sheaths (Fig. 3 C, c
and d). In addition, a decrease in the intensity of the B220-
stained cells was also evident in spleens from c-relDCT/DCT
mice compared with control littermates. In contrast to the
B cell areas, the T cell areas (periarterial lymphatic sheaths),
were not enlarged in spleens from mutant mice, as revealed
by the immunostaining with anti–TCR-a/b monoclonal
antibodies (Fig. 3 C, e and f).
Defective Clearance of L. Monocytogenes in c-relDCT/DCT
Mice. Although infectious disease as a primary cause of
the c-relDCT/DCT phenotype was ruled out (data not shown),
opportunistic bacterial infections were observed in older
c-relDCT/DCT mice. To examine whether c-relDCT/DCT mice
might fail to eliminate bacterial pathogens, we used the L.
monocytogenes model (42). Groups of wild-type and ho-
mozygous mutant mice were infected intraperitoneally
with L. monocytogenes, killed at day 5, and bacterial CFU
were determined in spleen, liver, and lung. As shown in
Fig. 4 A, c-relDCT/DCT mice had .20-fold higher listerial ti-
ters in all the tissues examined compared with control ani-
mals. This result defined an impaired capability of c-relDCT/DCT
mice in handling bacterial infections and explained the in-
creased susceptibility to bacterial infections of these mice
when kept in a non–pathogen-free environment.
Figure 3. Bone marrow hypoplasia, extramedullary hematopoiesis, and
lymphoid hyperplasia in c-relDCT/DCT mice. Single cell suspensions were
treated with LCK lysis buffer and an equivalent number of bone marrow
(A) and splenic (B) cells from c-relDCT/DCT and control littermates were
stained with anti–Mac-1 (A, a and b), anti–Ter 119 (A, c and d; and B, a
and b), and anti–Gr-1 (B, c and d) antibodies and analyzed by flow cytom-
etry. Results show a representative profile from quadruplicates of several
independent analyses. (C) Spleen sections from 5-mo-old control (a, c,
and e) or c-relDCT/DCT mice (b, d, and f) immunostaining with anti–Mac-1
(a and b), anti-B220 (c and d), or anti–TCR-a/b (e and f) mouse mono-
clonal antibodies. Photomicrographs were taken at a magnification of
12.5.  WP, white pulp. 978 Mice Lacking the Transcriptional Activation Domain of c-Rel
Reduced Production of NO and Cytokines in c-relDCT/DCT
Macrophages. To investigate whether migration is im-
paired in Dc-Rel macrophages, mice were injected with
thioglycollate. The total number of peritoneal inflamma-
tory cells elicited was comparable in control and c-relDCT/DCT
mice (Fig. 4 B a). However, the differential cell count re-
vealed a twofold reduction in the number of macrophages
and a relative increase in the number of polymorphonuclear
leukocytes in c-relDCT/DCT mice, indicating that recruit-
ment of macrophages is impaired in the mutant animals
(Fig. 4 B, b and c). The altered clearance of the facultative
intracellular bacterium L. monocytogenes in c-relDCT/DCT mice
may be due to reduced bactericidal activity of the mac-
rophage, which is known to be mediated by release of
toxic nitrogen intermediates (43). Resident c-relDCT/DCT
peritoneal macrophages after in vitro stimulation with LPS
and IFN-g had a significantly lower NO production com-
pared with control macrophages (Fig. 4 C). 
Cytokines synthesized by activated macrophages include,
among others, IL-1b, TNF-a, IL-6, and GM-CSF (44).
The production of these cytokines was compared in non-
stimulated and LPS/IFN-g–activated control and Dc-Rel
resident peritoneal macrophages (Fig. 4 D). Basal levels of
IL-1b (Fig. 4 D a), GM-CSF (Fig. 4 D b), TNF-a (Fig. 4
D c), and IL-6 (Fig. 4 D d) were reduced in nonstimulated
Dc-Rel resident peritoneal macrophages; however, upon
LPS and IFN-g activation, TNF-a and IL-6 production
was almost completely reestablished. This finding contrasts
with the production of IL-1b and GM-CSF by activated
macrophages, whereas cytokine levels secreted by Dc-Rel
macrophages were significantly reduced. 
Impaired Granuloma Formation in c-relDCT/DCT Mice.  The
intravenous administration of glucan to a variety of experi-
mental animals results in a marked proliferation of macrophages
and granuloma formation (32). Control and c-relDCT/DCT
mice were injected intravenously with glucan and after 24 h,
lung tissue sections were prepared for analysis of granuloma
formation (Fig. 4 E). In control lungs, multiple and massive
angiocentric granulomas were observed (Fig. 4 E a). Analy-
sis at higher magnification revealed that the granulomas were
composed primarily of granulocytes and, to a lesser extent,
by macrophages (Fig. 4 E b). In contrast, in c-relDCT/DCT
mice, lung compromise was minimal with small scattered
granulomas (Fig. 4 E c), composed primarily of macrophages
and rare granulocytes (Fig. 4 E d). This result indicates that
macrophage proliferation and granulocyte recruitment in
response to glucan injection is impaired in c-relDCT/DCT
mice. Since we have not detected c-Rel expression in
granulocytes (12), the impairment in granulocyte recruit-
ment observed after glucan injection is most probably due
to defective cytokine production by alveolar macrophages.
Collectively, these results define an essential need of a tran-
scriptionally active c-Rel in macrophages. 
c-relDCT/DCT Mice Display Impaired Antibody Production, B
Cell Proliferation, and Germinal Center Formation.  To eval-
uate the humoral immunity of c-relDCT/DCT mice, we mea-
Figure 4. Macrophage alter-
ations in c-relDCT/DCT mice. (A)
Defective clearance of L. monocy-
togenes. Mice were injected intra-
peritoneally with 2,500 CFU of
L. monocytogenes and killed 5 d
later. Each solid square (control
mice) or empty circle (c-relDCT/DCT
mice) represents the bacterial CFU
isolated from spleen, liver, or
lung homogenates of individual
animals. (B) Normal numbers of
total inflammatory cells (B a),
but reduced numbers of perito-
neal macrophages (b and c) in
c-relDCT/DCT mice. Representative
cytospin preparation from thiogly-
collate-elicited macrophages from
control (B b) and c-relDCT/DCT
mice (B c). (C) NO production
from unstimulated (solid bars) or
LPS/IFN-g–stimulated resting
peritoneal macrophages (hatched
bars). (D) Cytokine production
from unstimulated (solid bars) or
LPS/IFN-g–stimulated peritoneal
macrophages (hatched bars). Re-
sults represent absolute amounts
(mean  6 SD). (E) Reduced
granuloma formation in c-relDCT/
DCT mice. Control (a and b) and
c-relDCT/DCT (c and d) mice were
injected intravenously with glu-
can, killed 24 h later, and lung tissue sections were stained with hematoxylin and eosin. Photomicrographs were taken at magnifications of 250 (a and b),
25 (c and d), and 100 (e and f). M, macrophage; G, granulocyte. Arrowheads, granulomatous infiltration.979 Carrasco et al.
sured the basal production of immunoglobulins in naive
animals. Serum isotype levels from nonimmunized c-relDCT/DCT
mice and control littermates are shown in Fig. 5 A. Al-
though the levels of IgG1 (threefold), IgG2b (twofold), and
IgG3 (fourfold) in c-relDCT/DCT mice were reduced com-
pared with wild-type littermates (Fig. 5 A a), those of IgG2a
(twofold), IgM (threefold), and IgA (twofold) were increased
(Fig. 5 A b). 
Splenic B cells from control and c-relDCT/DCT mice were
stimulated with different agents over a 72-h period and
proliferation was monitored by [3H]thymidine incorpora-
tion. Control B cells stimulated with a-IgD-dex, LPS, ligand
for the mouse CD40 (mCD40L), or a-CD40 showed pro-
liferation, and these responses were further augmented by
IL-4 and IL-5 addition. Dc-Rel B cells showed only mini-
mal response to LPS and mCD40L and IL-4 plus IL-5, but
did not proliferate under other stimuli (Fig. 5 B). However,
when unpurified Dc-Rel B cells were used for in vitro pro-
liferation assays, significant levels of [3H]thymidine incor-
poration were observed (data not shown). These results in-
dicate that there are two different pathways leading to B
cell proliferation, one intrinsic and c-Rel dependent, and
another extrinsic, c-Rel independent, which requires addi-
tional exogenous stimuli.
The abnormal architecture of the spleen in c-relDCT/DCT
mice suggests that the immune responses dependent on cel-
lular interactions in the lymphatic follicles may not be fully
functional. Therefore, we immunized mice with SRBCs
and evaluated the formation of GCs 7 d later (Fig. 5 C).
The spleen of control mice had numerous GCs as defined
by central areas of cells that bind peanut agglutinin (PNA;
Fig. 5 C a) surrounded by IgD1 cells (Fig. 5 C b). In con-
trast, spleens of c-relDCT/DCT mice had reduced numbers and
poorly defined GCs (Fig. 5 C c and d). These results indi-
cate that clonal expansion of B cells in response to the T
cell–dependent antigen (SRBC) is impaired in c-relDCT/DCT
mice.
Normal Clearance of LCMV in c-relDCT/DCT Mice.  Acute
infection of adult mice with LCMV induces a protective
immunity and it has been shown that virus-specific CTLs
play an essential role in virus elimination from the infected
host (45). To examine whether a transcriptionally active
c-Rel is required to induce a CTL response, control and
c-relDCT/DCT mice were infected with LCMV and their ca-
pacity to clear virus loads from various organs was determined
at days 3 and 7 after virus inoculation. As shown in Fig. 6 A,
c-relDCT/DCT and control mice exhibited equivalent viral ti-
ters in all organs tested at 3 (Fig. 6 A a) or 7 (Fig. 6 A b) d
after inoculation. This result demonstrates that c-relDCT/DCT
mice can mount a protective CTL response against LCMV.
Normal Proliferative Responses and Cytokine Production in
c-relDCT/DCT–derived T Cells.  Proliferative response of T cells
from c-relDCT/DCT mice was comparable to that seen in con-
trol cells (Fig. 6 B). Equivalent levels of [3H]thymidine in-
corporation were observed in control and mutant T cells
after stimulation of either IL-2 or with a combination of
anti-CD3 plus anti-CD28.
 The cytokine secretion profile of normal and Dc-Rel T
cells in the absence of stimuli or after anti-CD3 plus anti-
CD28 stimulation is shown in Fig. 6 C. In the absence of
stimuli, cytokines were undetectable in either control or
Dc-Rel T cells (Fig. 6 C, a–c). Anti-CD3 plus anti-CD28
stimulation increased production of GM-CSF, TNF-a,
Figure 5. B cell alterations in c-relDCT/DCT mice. (A) c-relDCT/DCT mice
display defects in antibody production. The levels of serum immunoglob-
ulins (mg/ml) in naive 6–8-wk-old litter-matched mice were determined
by isotype-specific ELISA in control and c-relDCT/DCT mice. (B) Dc-Rel B
cells show defects in DNA synthesis in vitro. Splenic B cells (103 cells/ml)
isolated from control (solid bars) or c-relDCT/DCT (hatched bars) mice were
incubated for 72 h in various conditions: unstimulated, a-IgD-dex (3 ng/
ml), LPS (0.2 mg/ml), IL-4 (3,000 U/ml) 1 IL-5 (150 U/ml), a-IgD-dex
(3 ng/ml) 1 IL-4 (3,000 U/ml) 1 IL-5 (150 U/ml), mCD40L (1/2,000
vol/vol) 1 IL-4 (3,000 U/ml) 1 IL-5 (150 U/ml), or anti-CD40 mAb
(1.25 mg/ml). [3H]thymidine was added for the final 12 h, and cells were
then harvested for determination of [3H]thymidine incorporation. Values
represent the means in triplicate cultures 6 SD. (C) Absence of GCs in
spleen from immunized c-relDCT/DCT mice. Serial spleen sections from
control (a and b) and c-relDCT/DCT mice (c and d) were stained with peanut
agglutinin (a and c) or anti-IgD antibodies (b and d). Photomicrographs
were taken at a magnification of 50 (a–d). 980 Mice Lacking the Transcriptional Activation Domain of c-Rel
and IL-2 in both control and c-relDCT/DCT T cells. However,
quantitative differences were observed. For instance, the
levels of GM-CSF and TNF-a were higher in c-relDCT/DCT
T cells, whereas the levels of IL-2 production were equiva-
lent in control and c-relDCT/DCT T cells. 
Differential Alteration of kB-binding Activity in Dc-Rel B and
T Cells. The functional alterations observed in some hemato-
poietic cell compartments but not in others in c-relDCT/DCT
mice could be due to differential alterations in the NF-kB ac-
tivity. Thus, we determined the kB-binding activity of pu-
rified in vitro activated control and mutant T and B cells
(Fig. 7 A). Nuclear protein extracts from B cells (Fig. 7 A a)
and T cells (Fig. 7 A b) from control (lanes 1–6) and Dc-Rel
(lanes 7–12) cells were analyzed by EMSA using a palin-
dromic kB-binding site. Antibody challenge of the nuclear
extracts demonstrate that the major kB-binding complexes
in control B cells are p50/c-Rel heterodimers and p50/p50
homodimers, whereas in control T cells, p50/c-Rel and p50/
RelA heterodimers together with p50/p50 homodimers
are the major kB-binding complexes (Fig. 7 A b). In Dc-
Rel B cells, the major kB-binding complex is a p50/Dc-
Rel heterodimer (Fig. 7 A a), whereas in Dc-Rel T cells,
two major complexes containing Dc-Rel were identified,
Figure 7. Differential kB-binding activity of Dc-Rel in T and B cells.
(A) Control and c-relDCT/DCT–derived B (A a) or T cells (A b) were incu-
bated in the presence of LPS (10 mg/ml), or PMA (10 ng/ml) and PHA
(5 mg/ml), respectively, for 3 h and nuclear protein extracts were pre-
pared to analyze kB-binding activity by EMSA. Nuclear extracts were
challenged with the indicated antibodies. p.i., preimmune. (B) Represen-
tative CAT assays of cotransfection experiments performed in the S107
cell line. The expression vectors for Dc-Rel and c-Rel were transfected
either alone or in combination with p50 or RelA as described in Material
and Methods. The basal levels of CAT activity in cells transfected with
pMexneo vector have been subtracted before plotting.
Figure 6. Normal T cell functions in c-relDCT/DCT mice. (A) c-relDCT/DCT
mice clear LCMV infection. Control and c-relDCT/DCT mice were inocu-
lated with 1.2 3 105 PFU LCMV by intraperitoneal injection, killed 3 (A
a) or 7 (A b) D after LCMV infection, and virus titers of spleen, liver, and
lung were determined. Bars represent data (mean 6 SD) from six to nine
mice per genotype. (B) Normal T cell proliferation of Dc-Rel T cells.
Control or Dc-Rel lymph node–derived T cells were incubated with or
without various stimuli, and cell proliferation was measured by [3H]thy-
midine incorporation. (C) Cytokine production in control or Dc-Rel
lymph node T cells. Cells were incubated without (solid bars) or with
(hatched bars) aCD3 and aCD28. Cytokine levels in supernatants were
determined after 24 h. All cultures were performed in triplicate. 981 Carrasco et al.
RelA/Dc-Rel and p50/Dc-Rel heterodimers (Fig. 7 A b).
As expected, due to the COOH-terminal deletion present
in  Dc-Rel, the p50/Dc-Rel and RelA/Dc-Rel het-
erodimers migrate faster than p50/c-Rel and RelA/c-Rel
heterodimers, respectively.
The transcriptional activity of Dc-Rel complexes was
studied in cotransfected S107 cells (Fig. 7 B). These studies
demonstrate that the activity of the RelA/Dc-Rel het-
erodimer is similar to the wild-type RelA/c-Rel het-
erodimer (compare lanes 5 and 8), probably due to the
presence of one transcriptional activation domain in RelA.
The p50/Dc-Rel heterodimer is much less active than the
wild-type p50/c-Rel heterodimer (compare lanes 7 and 9),
most likely due to the absence of transcriptional activation
domains in both p50 and Dc-Rel. In summary, these results
indicate that the presence of p50/c-Rel activity is indis-
pensable for normal B cell function, but not for T cell
function.
Discussion
c-Rel was the first member of the Rel/NF-kB family of
transcriptional factors demonstrated to be a protooncogene.
v-Rel is the oncogene carried by the retrovirus of the retic-
uloendotheliosis virus strain T that produces lymphoprolif-
erative disorders in birds (17–20). The chicken v-Rel has
also been demonstrated to induce multicentric lymphoma/
leukemia in mammalian cells (34). Although all Rel/NF-kB
members contain the highly conserved RHD, they have a
highly divergent COOH-terminal end that in c-Rel,
RelA, and RelB confer powerful transcriptional activity
(24, 36, 46, 47). Interestingly, v-Rel represents a mutated
version of c-Rel in which one of the major differences is a
deletion of its COOH-terminal sequence (17–20). To bet-
ter understand the functional consequences of the COOH-
terminal truncation on the transforming capability of c-Rel
and the functional role of the different transcriptional acti-
vation domains among different Rel/NF-kB members, we
have generated mice in which the endogenous c-Rel pro-
tein has been replaced by a truncated version lacking the
transcriptional activation domain (c-relDCT/DCT mice). In this
paper, the initial characterization of the phenotype of
c-relDCT/DCT  mice is described. 
Multiple Hematopoietic Abnormalities and Lymphoid Hyper-
plasia in c-relDCT/DCT Mice.  In agreement with the broad
expression pattern of c-Rel in hematopoietic cell lineages
(12, 36), a complex spectrum of hematopoietic alterations
was observed in mice lacking the transcriptional activation
domain of c-Rel. c-relDCT/DCT mice showed increased sus-
ceptibility to bacterial infection, impaired bone marrow
hematopoiesis, and histopathologic alterations in hemato-
poietic tissues (including B cell hyperplasia). These alter-
ations appear to represent defects in the cross-regulation
between various hematopoietic cells, and for this reason, it
is difficult to sort out secondary from primary defects. For
instance, the fact that bone marrow hypoplasia was accom-
panied by compensatory extramedullary hematopoiesis in
the spleen indicates that there are no primary abnormalities
in hematopoietic precursors. Instead, there is an inappropri-
ate microenvironment in the bone marrow of c-relDCT/DCT
mice, probably related to altered cytokine production by
stromal cells, macrophages, B cells, or T cells. The defec-
tive GC formation in c-relDCT/DCT mice is likely due to the
structural alterations in the spleen, or due to functional al-
terations at some level in the network between macro-
phages, dendritic follicular cells, T cells, and B cells that are
essential for the normal development of GCs (48, 49). Un-
derstanding the primary cellular alterations in c-relDCT/DCT
mice will require specific cellular assays in purified single
cell populations. A successful example of this strategy is the
recent observation that isolated c-relDCT/DCT–derived B cells
exhibit selective defects in germline transcription and Ig
class switching (50). 
The fact that c-relDCT/DCT mice present lymphadenopathy
and lymphoid hyperplasia in stomach, liver, and lungs is
particularly interesting in light of the information that
chromosomal translocations associated with structural alter-
ations of the Rel/NF-kB family of proteins have been doc-
umented in several cases of human lymphomas (51–53).
More specifically, c-rel rearrangements in several human
non-Hodgkin’s lymphomas have been found. In one cell
line derived from a pre–T diffuse large cell human lym-
phoma, several abnormal c-rel cDNAs were isolated that
encoded a large portion of the RHD that is fused to cellu-
lar sequences of unknown origin (53). The explanation of
lymphoid hyperplasia found in older c-relDCT/DCT mice is
complex and may be related to a combination of different
factors. The fact that in vitro [3H]thymidine incorporation
was decreased in purified c-relDCT/DCT B cells but not differ-
ent from control unpurified B cells indicates that the trun-
cated Dc-Rel protein does not affect the intrinsic mitoge-
nic activity of B cells. Instead, it may affect the external
signals regulating B cell proliferation. Cytokines are potent
regulatory molecules secreted by cells of the immune sys-
tem; deletion of certain cytokines in mouse mutants leads
to immune dysregulation and expansion of some hemato-
poietic lineages (44). For instance, IL-8–deficient mice ex-
hibit lymphoadenopathy, which results from an increase in
B cells, and splenomegaly, which results from an increased
number of metamyelocytes, band cells, and mature neutro-
phils (54). GM-CSF null mice present extensive lymphoid
hyperplasia associated with lung airways and blood vessels
(55). Interestingly, disruption of cytokine production and
myeloid hyperplasia has been observed in mice deficient in
RelB (26), and in mice lacking the COOH-terminal
ankyrin domain of NF-kB2 (56). 
The fact that B cell hyperplasia appears at later times, and
in older animals, indicates that the lymphoid expansion
may be related to a reduced clearance of aged cells by the
reticuloendothelial system. This possibility is particularly
attractive in light of the observation of reduced total num-
ber and functional alterations of macrophages in c-relDCT/DCT
mice. It is also possible that a secondary event may lead to
an increase in B cell proliferation in older c-relDCT/DCT
mice. In this sense, it is important to mention that there are
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cells and v-Rel in transformed T cells (34). For example, a
significant amount of Dc-Rel is found in the nucleus (data
not shown) and increased kB-binding activity, mainly
composed of p50/Dc-Rel, is observed in Dc-Rel cells, as in
v-Rel–transformed T cells. In addition, similar to v-Rel
transgenic mice, lymphoid hyperplasia in c-relDCT/DCT ani-
mals was evident after a long period of latency, suggesting
that a secondary event is required for the appearance of this
phenotype. We have previously expressed Dc-Rel in trans-
genic thymocytes by using the lck T cell–specific promoter
(34). In this model, Dc-Rel did not produce T cell abnor-
malities, suggesting that the use of a rearranged c-rel gene
under the control of its own regulatory elements, as in
c-relDCT/DCT mice, is required to recapitulate the situation
found in lymphoproliferative disorders.
Molecular Mechanisms Underlying c-Rel and Dc-Rel Func-
tion.  The phenotype of c-relDCT/DCT mice has quantitative
and qualitative differences from the phenotype described
previously for mice lacking the entire c-Rel molecule (21–
23) with c-relDCT/DCT mice showing a more severe pheno-
type. Since the same strain of mice were used to generate
both c-rel2/2 and c-relDCT/DCT mice, these differences must
be attributable to other factors. In c-relDCT/DCT mice, a tran-
scriptionally inactive molecule has been generated that re-
tains its capability to bind DNA and interact with other Rel/
NF-kB members. The absence of phenotypic alterations in
heterozygous c-rel1/DCT mice indicate that Dc-Rel does not
behave as a transdominant mutant protein of c-Rel. We
speculate that by keeping the original niche of c-Rel, Dc-
Rel may prevent partial compensation of its function by
other Rel/NF-kB members in some cell lineages, which
may be the case in c-rel2/2 mice. The degree of compensa-
tion in c-rel2/2 mice depends on the cell type, its physio-
logic state, and the level of expression of other Rel/NF-kB
members. In the case of Dc-Rel, its degree of inactivation
will also depend on similar parameters, because of the pos-
sibility of forming either transcriptionally inactive or tran-
scriptionally active heterodimers. For instance, in c-rel2/2,
but not in c-relDCT/DCT mice, defective proliferation of T
cells and cytokine production by T cells was identified (22).
Band shift assays performed with nuclear protein extracts
from control T cells showed p50/RelA heterodimers as
one of the major kB-binding components, whereas in Dc-
Rel T cells, a significant amount of complexes containing
Dc-Rel were detected, including Dc-Rel/RelA het-
erodimers (Fig. 7 A a). Since cotransfection transcriptional
assays demonstrated that Dc-Rel/RelA heterodimers are as
active as p50/RelA heterodimers (Fig. 7 B, lanes 6 and 8),
it is possible that T cell proliferation and cytokine produc-
tion are normal in c-relDCT/DCT mice due to cellular-specific
compensation by Dc-Rel/RelA heterodimers. On the
other hand, in c-rel2/2 mice, T cell proliferation is altered
because other Rel family proteins in the kB-binding com-
plexes do not compensate for the loss of c-Rel in T cells
(22). Alteration in B cell function in c-relDCT/DCT mice is
likely related to the fact that the major kB-binding activity
in normal B cells is composed of p50/c-Rel heterodimers
(Fig. 7 A a), which cannot be substituted by the transcrip-
tional inactive p50/Dc-Rel heterodimer present in Dc-Rel
B cells (Fig. 7 B, lanes 7 and 9). Quantitative differences in
the level of cytokine production in resting macrophages
have also been observed between c-rel2/2 and c-relDCT/DCT
mice. For instance, GM-CSF and IL-6 production are de-
creased in c-relDCT/DCT mice, but increased in c-rel2/2 mice.
Since p50/c-Rel is the major kB-binding activity in resting
macrophages (data not shown and reference 23), replace-
ment with the inactive p50/Dc-Rel heterodimer in Dc-Rel
macrophages results in decreased expression of GM-CSF
and IL-6 (Fig. 7 B, lanes 7 and 9). In c-rel2/2 macrophages,
the p50/c-Rel heterodimer is substituted by the p50/RelA
heterodimer that is a more powerful transcriptional activa-
tor (Fig. 7 B, lanes 6 and 7). In this way, the expression of
GM-CSF and IL-6 genes will likely increase, instead of de-
creasing as in resting c-rel2/2 macrophages. 
The function of individual Rel/NF-kB family members
has been studied by a gene targeting approach (13). The
phenotypic differences between c-rel2/2 and c-relDCT/DCT
mice suggest the existence of partial compensation of c-Rel
function by other Rel/NF-kB members. Molecular com-
pensation has also been suggested in mice deficient for
other members of the Rel/NF-kB family. For instance,
mice lacking only NF-kB1 or NF-kB2 do not show alter-
ations in bone development. However, mice lacking both
NF-kB1 and NF-kB2 develop osteopetrosis due to a defect
in osteoclast differentiation (57).
The c-relDCT/DCT mice are a useful model system to study in
more detail the role of NF-kB factors in cells of the immune
system. The pathological changes observed in c-relDCT/DCT
mice may help to understand the pathogenesis of human
immune and lymphoproliferative disorders.
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